Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier. - Di K; Lloyd GK; Abraham V; MacLaren A; Burrows FJ; Desjardins A; Trikha M; Bota DA (Neuro-oncology, 2016)